Literature DB >> 7903579

Differential 3' polyadenylation of the Huntington disease gene results in two mRNA species with variable tissue expression.

B Lin1, J M Rommens, R K Graham, M Kalchman, H MacDonald, J Nasir, A Delaney, Y P Goldberg, M R Hayden.   

Abstract

Recently a novel gene containing a CAG trinucleotide repeat that is expanded on HD chromosomes has been identified(1). This gene was shown to detect a single transcript of 10-11 kb by RNA hybridization. We have however, previously identified three cDNAs which are part of the same gene that have been shown to detect two distinct transcripts of 10 kb and one that is significantly larger(2,3). These different mRNA species could be due to use of alternate transcription start sites, alternate splicing or selection of different polyadenylation sites. We have identified cDNA clones spanning the HD gene including two (HD12 and HD14) that share identical protein coding sequences but differ in size and sequence of their 3' untranslated region. HD14 has 3,360 base pairs of additional sequence distal to the previously published 3' end (1). RNA hybridization has revealed that the larger 13.7 kb fragment is the predominant transcript in human brain. cDNA fragments unique to HD14 detected only the larger transcript. Sequence analysis identified two different putative polyadenylation sequences at position 10,326 and 13,645 of the HD14 cDNA. These findings indicate that the two observed mRNA species originate from a single gene and that differential polyadenylation leads to transcripts of different size. The relative increased abundance of the larger transcript in human brain may provide some insights into the mechanism by which a widely expressed gene may exert tissue specific effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7903579     DOI: 10.1093/hmg/2.10.1541

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

1.  Modeling Huntington's disease in cells, flies, and mice.

Authors:  S Sipione; E Cattaneo
Journal:  Mol Neurobiol       Date:  2001-02       Impact factor: 5.590

2.  Autoregulation of GLD-2 cytoplasmic poly(A) polymerase.

Authors:  Labib Rouhana; Marvin Wickens
Journal:  RNA       Date:  2006-12-12       Impact factor: 4.942

Review 3.  Alternative poly(A) site selection in complex transcription units: means to an end?

Authors:  G Edwalds-Gilbert; K L Veraldi; C Milcarek
Journal:  Nucleic Acids Res       Date:  1997-07-01       Impact factor: 16.971

Review 4.  Huntington's disease: the coming of age.

Authors:  Mritunjay Pandey; Usha Rajamma
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

5.  Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.

Authors:  Kyung-Hee Kim; Kawther Abu Elneel; Jun Wan Shin; Jae Whan Keum; David Seong; Seung Kwak; Ramee Lee; James F Gusella; Marcy E MacDonald; Ihn Sik Seong; Jong-Min Lee
Journal:  J Hum Genet       Date:  2019-07-11       Impact factor: 3.172

6.  Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression.

Authors:  K Savitsky; M Platzer; T Uziel; S Gilad; A Sartiel; A Rosenthal; O Elroy-Stein; Y Shiloh; G Rotman
Journal:  Nucleic Acids Res       Date:  1997-05-01       Impact factor: 16.971

7.  Alterations in mRNA 3' UTR Isoform Abundance Accompany Gene Expression Changes in Human Huntington's Disease Brains.

Authors:  Lindsay Romo; Ami Ashar-Patel; Edith Pfister; Neil Aronin
Journal:  Cell Rep       Date:  2017-09-26       Impact factor: 9.423

8.  Geographical distribution of haplotypes in Swedish families with Huntington's disease.

Authors:  E Almqvist; S Andrew; J Theilmann; P Goldberg; J Zeisler; U Drugge; U Grandell; M Tapper-Persson; B Winblad; M Hayden
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

Review 9.  Therapeutic approaches to preventing cell death in Huntington disease.

Authors:  Anna Kaplan; Brent R Stockwell
Journal:  Prog Neurobiol       Date:  2012-08-28       Impact factor: 11.685

10.  Dominant effects of the Huntington's disease HTT CAG repeat length are captured in gene-expression data sets by a continuous analysis mathematical modeling strategy.

Authors:  Jong-Min Lee; Ekaterina I Galkina; Rachel M Levantovsky; Elisa Fossale; Mary Anne Anderson; Tammy Gillis; Jayalakshmi Srinidhi Mysore; Kathryn R Coser; Toshi Shioda; Bin Zhang; Matthew D Furia; Jonathan Derry; Isaac S Kohane; Ihn Sik Seong; Vanessa C Wheeler; James F Gusella; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2013-04-16       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.